Search

everythinglearnresearchcommunity

for

Search:↓

PCOS is a common hormonal disorder in women, treated with lifestyle changes and medications like hormonal contraceptives and metformin.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

Oxidative stress is a key factor in the development of Polycystic Ovary Syndrome, and weight management can improve symptoms.

Nanocarrier-loaded gels improve drug delivery for cancer, skin conditions, and hair loss.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

Skin grafts are effective for chronic leg ulcers, especially autologous split-thickness grafts for venous ulcers, but more data is needed for diabetic ulcers.

Genes and hormones cause hair loss, with four genes contributing equally.

Finasteride improves hidradenitis suppurativa but not for child-bearing women.

Minoxidil effectively controls blood pressure in severe cases, but may cause fluid retention and edema.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

Polycystic Ovary Syndrome is common but often undiagnosed, and early treatment is important to prevent health problems.

Ice-skating athletes often have skin problems due to cold, infections, and inflammation, needing careful treatment and prevention.

Jojoba oil is highly valued for its diverse medicinal and industrial uses.

Some herbs and their components might help treat hair loss by affecting various biological pathways, but more research and regulation are needed.

Excessive hair growth can be assessed by history, exam, and blood tests, and treated with medication like dexamethasone, birth control pills, and spironolactone.

Hidradenitis suppurativa may be related to hormones and patients often have metabolic disorders; more research is needed to understand this connection.

Male hormones, or androgens, affect women's health in areas like mood and bone density, and hormone replacement therapy using antiandrogenic progestogens can improve mood disorders and alertness in menopausal women.

The review suggests that understanding and treating the psychological aspect of skin disorders is important and calls for more collaboration in this field.

Early and personalized treatment for hair loss in young people is crucial to prevent permanent damage and should include psychological support.

Some plants used in traditional medicine may help treat cancer because they contain proteins that can inactivate ribosomes.

Hormones during pregnancy and lactation keep skin stem cells inactive, preventing hair growth.

The mineralocorticoid receptor may play a role in skin and hair health and could be a new target for treating related disorders.

Systemic glucocorticosteroids are a primary treatment for various skin conditions but require careful management due to potential side effects and relapses.

Gene therapy has potential as a future treatment for Hutchinson-Gilford progeria syndrome.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

Finasteride and flutamide effectively reduce hirsutism in PCOS women, with flutamide also lowering hormone levels.

Healthy women tend to lose more hair in July and April, and the least in February.

Sweat glands and hair follicles are structurally connected within a specific layer of skin fat.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Some hormone-related drugs may protect brain cells in Parkinson's disease differently in men and women.